Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Coverage | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 0 | 0 | $ -302.67M |
3/31/2025 | $ 0 | 0 | $ -286.52M |
12/31/2024 | $ 0 | 0 | $ -274.9M |
9/30/2024 | $ 0 | 0 | $ -258.86M |
6/30/2024 | $ 0 | 0 | $ -241.19M |
3/31/2024 | $ 0 | 0 | $ -204.92M |
12/31/2023 | $ 0 | 0 | $ -160.6M |
9/30/2023 | $ 0 | 0 | $ -142.15M |
6/30/2023 | $ -225K | 0 | $ -126.04M |
3/31/2023 | $ -225K | 0 | $ -130.97M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for SYNDAX PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -68.36M ] / CapEx [ $ 0 ]
(=) CapEx Coverage [ 0 ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.21K |
---|---|
min | 0.01 |
max | 17.91 |
average | 4.41 |
median | 3.01 |
std | 4.02 |